Power Law company profile

Umoja Biopharma

Biotech & Life Sciences · Seattle, United States · Founded 2019 Unicorn

Developing a new approach to cancer therapy that retools a patient’s immune system in vivo, enhancing the body’s natural capacity to fight cancer

Valuation

$1–2.5B

Latest valuation · 2026

Unlock exact value

Headcount

100–500

Current team size

Unlock exact value

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

19 investors on Umoja Biopharma's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 1 investor entered at this stage

DCVC

Series A 2 investors entered at this stage

Qiming Venture Partners USA

MPM BioImpact

Series B+ 16 investors entered at this stage

Temasek

Cormorant Asset Management

Presight Capital

Emerson Collective

RTW Investments

K2 HealthVentures

CaaS Capital Management

Myeloma Investment Fund

SoftBank Vision Fund

Alexandria Venture Investments

University of Minnesota Twin Cities

Casdin Capital

ARK Invest

Double Point Ventures

SoftBank

DCVC Bio

Global footprint

Where Umoja Biopharma has talent and traffic

AI talent share

0.9% of workforce is AI talent
(2 of 224 staff)

Core AI00%

Other AI20.89%

Non-AI workforce22299.11%

Workforce by country

1 countries with
team presence

🇺🇸 United States99.3%

1 country shown

Web traffic by country

8.9K monthly visits
across markets

🇺🇸 United States87.6%

🇮🇳 India6.7%

🇦🇺 Australia5.6%

Top 3 markets shown

Patent intelligence

$2M patent portfolio · 16 active families

Estimated portfolio value

$2M

0.18% of valuation · 419.7× smaller than top peer BioNTech ($780M)

16 active patent families

Where Umoja Biopharma innovates Molecular biologyCell biologyVirusCellPolynucleotide

Where Umoja Biopharma concentrates vs peers

Each axis is a top-10 topic across Umoja Biopharma and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Umoja Biopharma

An AI-synthesized read of the highest-engagement posts about Umoja Biopharma on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Umoja Biopharma on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles